Richard Savdie
Garvan Institute of Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Richard Savdie.
BJUI | 2010
Nicolas Doumerc; Carlo Yuen; Richard Savdie; M. Bayzidur Rahman; Kris K. Rasiah; Ruth Pe Benito; Warick Delprado; Jayne Matthews; Anne-Maree Haynes
Study Type – Therapy (case series) Level of Evidence 4
BJUI | 2012
Richard Savdie; Lisa G. Horvath; Ruth Pe Benito; K. Rasiah; Anne-Maree Haynes; Mark Chatfield; Jennifer Turner; Warwick Delprado; Susan M. Henshall; Robert L. Sutherland; James G. Kench
Study Type – Prognosis (case series)
BJUI | 2012
Benjamin M. Moore; Richard Savdie; Ruth PeBenito; Anne-Maree Haynes; Jayne Matthews; Warick Delprado; K. Rasiah
Study Type – Therapy (case series)
BJUI | 2016
Minh Tran; James Thompson; Maret Böhm; Marley Pulbrook; Daniel Moses; Ron Shnier; Phillip Brenner; Warick Delprado; Anne-Maree Haynes; Richard Savdie
To evaluate the accuracy of combined multiparametric magnetic resonance imaging (mpMRI) and transperineal template‐guided mapping biopsy (TTMB) for identifying lobes with significant prostate cancer (PCa) for the application of hemi‐ablative focal therapy (FT).
BJUI | 2012
Richard Savdie; James Symons; Daniel Spernat; Carlo Yuen; Ruth Pe Benito; Anne Maree Haynes; Jayne Matthews; K. Rasiah; Raj Jagavkar; Changhong Yu; Gerald Fogarty; Michael W. Kattan; Phillip Brenner; Robert L. Sutherland
Objective • To compare long‐term biochemical control of high‐risk prostate cancer in those men receiving high‐dose rate brachytherapy (HDRB) and radical prostatectomy (RP).
Radiology | 2017
Shirin Sabouri; Silvia D. Chang; Richard Savdie; Jing Zhang; Edward C. Jones; S. Larry Goldenberg; Peter C. Black; Piotr Kozlowski
Purpose To assess the feasibility of luminal water imaging, a quantitative T2-based magnetic resonance (MR) imaging technique, for the detection and grading of prostate cancer (PCa). Materials and Methods Eighteen patients with biopsy-proven PCa provided informed consent to be included in this institutional human ethics board-approved prospective study between January 2015 and January 2016. Patients underwent 3.0-T MR imaging shortly before radical prostatectomy. T2 distributions were generated with a regularized non-negative least squares algorithm from multiecho spin-echo MR imaging data. From T2 distributions, maps of seven MR parameters, Ncomp, T2short, T2long, geometric mean T2 (gmT2), luminal water fraction (LWF), Ashort, and Along, were generated and compared with digitized images of hematoxylin-eosin-stained whole-mount histologic slices. A paired t test was used to determine significant differences between MR parameters in malignant and nonmalignant tissue. Correlation with Gleason score (GS) was evaluated with the Spearman rank correlation test. Diagnostic accuracy was evaluated by using logistic generalized linear mixed-effect models and receiver operating characteristic (ROC) analysis. Results The average values of four MR parameters (gmT2, Ashort, Along, and LWF) were significantly different between malignant and nonmalignant tissue. All MR parameters except for T2long showed significant correlation (P < .05) with GS in the peripheral zone. The highest correlation with GS was obtained for LWF (-0.78 ± 0.11, P < .001). ROC analysis demonstrated high accuracy for tumor detection, with the highest area under the ROC curve obtained for LWF (0.97 in the peripheral zone and 0.98 in the transition zone). Conclusion Results of this pilot study demonstrated the feasibility of luminal water imaging in the detection and grading of PCa. A study with a larger cohort of patients and a broader range of GS is required to further evaluate this new technique in clinical settings.
Cuaj-canadian Urological Association Journal | 2018
Samrad Ghavimi; Hamidreza Abdi; Jennifer Waterhouse; Richard Savdie; Silvia D. Chang; Alison C. Harris; Lindsay Machan; Martin Gleave; Alan So; Larry Goldenberg; Peter C. Black
INTRODUCTION The natural history of prostatic lesions identified on multiparametric magnetic resonance imaging (mpMRI) is largely unknown. We aimed to describe changes observed over time on serial MRI. METHODS All patients with ≥2 MRI studies between 2008 and 2015 at our institution were identified. MRI progression was defined as an increase in Prostate Imaging Reporting and Data System (PI-RADS; version 2) or size of existing lesions, or the appearance of a new lesion PIRADS ≥4. Patients on active surveillance (AS) were analyzed for correlation of MRI progression to biopsy reclassification. RESULTS A total of 83 patients (54 on AS and 29 for diagnostic purposes) underwent serial MRI, with a mean interval of 1.9 years between scans. At baseline, 115 lesions (66 index, 49 non-index) were identified. Index lesions were more likely than non-index lesions to increase in size ≥2 mm (36.2 vs. 7.3 %; p=0.002). Overall progression was more likely to be seen among the index cohort (34.8 vs. 7.6%; p<0.001). New lesions with PIRADS ≥4 were seen on second imaging in 13 (16.5%) men, and became the index lesion in 29 cases (34.9%). Eighteen men on AS showed evidence of MRI progression (five with new lesions, 13 with progression of a previous lesion). Biopsy reclassification was present in three men (16.7%) with and seven men without MRI progression (19.4%). CONCLUSIONS Overall changes in size and PIRADS scores of index lesions on MRI were small. New lesions were common, but usually did not alter management.
The Prostate | 2016
Hannah M. Bruce; Ruta Gupta; Richard Savdie; Anne-Maree Haynes; Kate Lynette Mahon; Hui-Ming Lin; James G. Kench; Lisa G. Horvath
Positive surgical margins (PSMs) in localized prostate cancer (PC) confer a two‐ to three‐fold increased risk of biochemical relapse (BR). Absent/weak AZGP1 expression and Gleason grade ≥4 at the margin are each independent predictors of BR in patients with PSMs. Our study aimed to determine whether the biomarkers AZGP1 expression and Gleason grade at the site of a PSM are significant independent markers of biochemical and clinical relapse (CR) when modeled together and whether one of these biomarkers may be superior in its capacity to predict outcome.
BJUI | 2018
Ilan Gielchinsky; John I. Chang; Thomas Cusick; Warick Delprado; Quoc Nguyen; Carlo Yuen; Richard Savdie; Maret Böhm; Anne-Maree Haynes; Matthijs J. Scheltema
To evaluate the clinical presentation and treatment outcomes of prostate cancer (PCa) in 432 consecutive patients aged < 50 years in the prostate‐specific antigen (PSA) era.
Minimally Invasive Surgery | 2015
Francis Ting; Richard Savdie; Sam Chopra; Carlo Yuen; Phillip Brenner
Introduction and Objectives. To demonstrate the safety and efficacy of the robot-assisted partial nephrectomy (RAPN) technique in an Australian setting. Methods. Between November 2010 and July 2014, a total of 76 patients underwent 77 RAPN procedures using the Da Vinci Surgical System© at our institution. 58 of these procedures were performed primarily by the senior author (PB) and are described in this case series. Results. Median operative time was 4 hours (range 1.5–6) and median warm ischaemic time (WIT) was 8 minutes (range 0–30) including 11 cases with zero ischaemic time. All surgical margins were clear with the exception of one patient who had egress of intravascular microscopic tumour outside the capsule to the point of the resection margin. Complications were identified in 9 patients (15.8%). Major complications included conversion to open surgery due to significant venous bleeding (n = 1), reperfusion injury (n = 1), gluteal compartment syndrome (n = 1), DVT/PE (n = 1), and readmission for haematuria (n = 1). Conclusion. This series demonstrates the safety and efficacy of the RAPN technique in an Australian setting when performed by experienced laparoscopic surgeons in a dedicated high volume robotic centre.